Protein supplement effect on the growth and immune system in preterm infants .
Early Phase 1
- Conditions
- growth and immune disorders in preterm infants.P05,P07
- Registration Number
- IRCT2016041927474N1
- Lead Sponsor
- Dr Seyed Mohammad Omrani Vice Chancellor for research of Shahrekord University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Enclusion criteria:Preterm infant with w<1500 gr and gestional age<32 weeks that admit in NICU (Hajar Hospital) from Desember 2015 until May 2016.
Exclusion critaria:Congenital malformations; NEC; Major surjery; Intra uterian infections; Koromosomal disorders; Sepsis.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight. Timepoint: Pre intervention and daily to end of intervention. Method of measurement: Digitaly scale /gram.;Head circumambient. Timepoint: Pre intervention,first and second week and end of intervention. Method of measurement: Non elastic meter/cm.;Length. Timepoint: Pre intervention,first and second week and end of intervention. Method of measurement: Non elastic meter/cm.;Neutrophil cell count. Timepoint: Pre and post intervention. Method of measurement: cbc.diff %.;Lymphocyte. Timepoint: Pre and post intervention. Method of measurement: cbc.diff %.;IgG. Timepoint: Pre and post intervention. Method of measurement: ELISA/mg/dl.;IgM. Timepoint: Pre and post intervention. Method of measurement: ELISA/mg/dl.;IgA. Timepoint: Pre and post intervention. Method of measurement: ELISA/mg/dl.
- Secondary Outcome Measures
Name Time Method PH. Timepoint: Pre intervention,first and second week and post intervention. Method of measurement: ABG/m. mol.;BUN. Timepoint: Pre intervention,first and second week and post intervention. Method of measurement: BLOOD SAMPLE/mg/dl.